Using the COM-B framework to elucidate facilitators and barriers to COVID-19 vaccine uptake in pregnant women: a qualitative study

被引：0
作者：
Lynsey Patterson
Emma Berry
Carole Parsons
Bronagh Clarke
Alison Little
Jillian Beggs
Antony Chuter
Tracy Jackson
Yingfen Hsia
Hannah McGrath
Catherine Millman
Siobhan Murphy
Declan T. Bradley
Sarah Milligan
机构：
[1] Public Health Agency,Centre for Public Health
[2] Queen’s University Belfast,School of Psychology
[3] Queen’s University Belfast,School of Pharmacy
[4] Queen’s University Belfast,Centre for Neonatal and Paediatric Infection
[5] PPI,undefined
[6] Usher Institute,undefined
[7] University of Edinburgh,undefined
[8] St George’s University of London,undefined
来源：
BMC Pregnancy and Childbirth | / 23卷
关键词：
COVID-19 vaccination; Pregnancy; Qualitative; Facilitators; Barriers; COM-B;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Since April 2021, COVID-19 vaccines have been recommended for pregnant women. Despite this, COVID-19 vaccine uptake in this group is low compared to the non-pregnant population of childbearing age. Our aim was to understand barriers and facilitators to COVID-19 vaccine uptake among pregnant women in Northern Ireland using the COM-B framework, and so to make recommendations for public health interventions. The COM-B proposes that human behaviour is influenced by the extent to which a person has the capability, opportunity, and motivation to enact that behaviour. Understanding the factors underpinning behaviour through this lens helps discern what needs to change to change behaviour, therefore supporting the development of targeted interventions.
引用
收藏
相关论文
共 174 条
  • [1] Doherty M(2016)Vaccine impact: Benefits for human health Vaccine 34 6707-6714
  • [2] Buchy P(2013)Exclusion of pregnant women from industry-sponsored clinical trials Obstet Gynecol 122 1077-81
  • [3] Standaert B(2021)Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study Am J Obstet Gynecol. 225 522.e1-522.e11
  • [4] Giaquinto C(2022)Pregnancy and risk of COVID-19: a Norwegian registry-linkage study BJOG. 129 101-9
  • [5] Prado-Cohrs D(2021)Maternal and neonatal morbidity and mortality among pregnant women with and without covid-19 infection: the intercovid multinational cohort study JAMA Pediatr 175 817-826
  • [6] Shields KE(2022)Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study BMJ 17 e071416-585.e16
  • [7] Lyerly AD(2023)Reductions in stillbirths and preterm birth in COVID-19–vaccinated women: a multicenter cohort study of vaccination uptake and perinatal outcomes Am J Obstet Gynecol 228 585.e1-457
  • [8] Gurol-Urganci I(2021)Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women JAMA 326 728-117
  • [9] Jardine JE(2023)Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study Lancet 401 447-101
  • [10] Carroll F(2021)COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population. Di Gennaro F, editor PLoS One. 16 e0248892-2
12345678910